Keyphrases
Hemophilia
100%
Recombinant Activated Factor VII (rFVIIa)
71%
Bleeding
66%
Continuous Infusion
51%
Hemophilia Patients
51%
Hemophiliacs
33%
Severe Haemophilia A
25%
Bleeding Episodes
23%
Platelets
22%
Fibrinogen
21%
Hemostasis
19%
Coagulopathy
18%
Hepatitis C
18%
Thrombin Generation
17%
Fibrin Glue
16%
Clot Formation
16%
Hemophilia B
16%
Israeli
15%
Tranexamic Acid
14%
Factor VIII Concentrate
14%
Postoperative Bleeding
14%
AIDS/HIV
14%
Platelet Function
13%
Factor Concentrates
13%
Dental Extraction
13%
Coagulation Factors
12%
Platelet Aggregation
12%
Fibrinolysis
12%
Factor XI Deficiency
11%
Hemarthrosis
11%
Israel
11%
Rotational Thromboelastometry (ROTEM)
11%
Von Willebrand Factor
10%
Trauma Patients
10%
Fibrin Sealant
10%
Trauma
10%
Blood Loss
10%
Factor VIII Gene
9%
Fresh Whole Blood
9%
Knee
9%
Thrombocytopenia
9%
Factor VIII (FVIII)
8%
Chronic Synovitis
8%
Bleeding Tendency
8%
Local Hemostasis
8%
Surgical Procedures
8%
Polymorphism
8%
Haemophilia Treatment Centre
8%
Clinical Experience
8%
Von Willebrand Disease
8%
Medicine and Dentistry
Bleeding
77%
Haemophilia
69%
Blood Clotting Factor 8
34%
Haemophilia A
32%
Fibrin Glue
30%
Hemostat
30%
Blood Stasis
30%
Factor VII
29%
Continuous Infusion
29%
Platelet
27%
Injury
27%
Patient with Hemophilia
26%
Coagulopathy
22%
Tooth Extraction
19%
Hepatitis C
15%
Blood Clotting
15%
Thrombin
15%
Thrombocyte Function
14%
Blood Clotting Factor
13%
Tranexamic Acid
13%
Ciclonicate
12%
Fibrinogen
12%
Recombinant Blood Clotting Factor 7a
12%
Hemarthrosis
11%
Bleeding Diathesis
10%
In Vitro
10%
Infusion
10%
Postoperative Hemorrhage
10%
Antithrombotic
9%
Knee
9%
Bleeding Disorder
9%
Surgical Technique
9%
Cardiopulmonary Bypass
8%
Thrombocyte Aggregation
8%
Disease
8%
Anticoagulant Therapy
7%
Limb
7%
Synovitis
7%
Liver Fibrosis
7%
Factor XI
7%
Haemophilia B
7%
FibroTest
7%
Placebo
7%
Prematurity
7%
Hematoma
7%
Human Immunodeficiency Virus
6%
Blood Clotting Factor 8 Inhibitor
6%
Substitution Therapy
6%
Bone Cyst
6%
Bleeding Time
6%
Pharmacology, Toxicology and Pharmaceutical Science
Bleeding
53%
Blood Clotting Factor 8
50%
Haemophilia
47%
Haemophilia A
40%
Blood Clotting Factor 7
29%
Injury
25%
Recombinant Blood Clotting Factor 7a
24%
Hemostatic Agent
22%
Pharmacokinetics
20%
Haemophilia B
18%
Blood Clotting Disorder
18%
Fibrinogen
17%
Thrombin
15%
Blood Stasis
14%
Ciclonicate
14%
Von Willebrand Factor
14%
Blood Clotting Factor
14%
Blood Clotting Factor 9
12%
Hepatitis C
10%
Recombinant Blood Clotting Factor 9
10%
Blood Clotting Factor 8 Concentrate
9%
Postoperative Hemorrhage
8%
Von Willebrand Disease
8%
Warfarin
8%
Fusion Protein
7%
Blood Clotting Factor 13
7%
Anticoagulant Agent
7%
Thrombocytopenia
7%
Blood Clotting Factor 11
7%
Thromboplastin
6%
Hemarthrosis
6%
Tissue Plasminogen Activator
6%
HIV
6%
Bleeding Disorder
5%
Activated Prothrombin Complex
5%
Bleeding Tendency
5%
Adverse Event
5%
Prothrombin
5%
Fibrin Glue
5%
Liver Fibrosis
5%
Thrombin Activatable Fibrinolysis Inhibitor
5%
Blood Clotting Factor 8 Inhibitor
5%
Amiodarone
5%
Chitosan
5%
Recombinant Blood Clotting Factor 8
5%
Fibrinogen Concentrate
5%